ZA997113B - Process and intermediates for preparing 5-lipoxygenase inhbitors. - Google Patents

Process and intermediates for preparing 5-lipoxygenase inhbitors.

Info

Publication number
ZA997113B
ZA997113B ZA9907113A ZA997113A ZA997113B ZA 997113 B ZA997113 B ZA 997113B ZA 9907113 A ZA9907113 A ZA 9907113A ZA 997113 A ZA997113 A ZA 997113A ZA 997113 B ZA997113 B ZA 997113B
Authority
ZA
South Africa
Prior art keywords
inhbitors
lipoxygenase
intermediates
preparing
lipoxygenase inhbitors
Prior art date
Application number
ZA9907113A
Other languages
English (en)
Inventor
Charles Kwok-Fung Chiu
Ravi Mysore Shanker
Douglas John Meldrum Allen
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA997113B publication Critical patent/ZA997113B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
ZA9907113A 1998-12-22 1999-11-15 Process and intermediates for preparing 5-lipoxygenase inhbitors. ZA997113B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11322198P 1998-12-22 1998-12-22

Publications (1)

Publication Number Publication Date
ZA997113B true ZA997113B (en) 2001-05-15

Family

ID=22348241

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9907113A ZA997113B (en) 1998-12-22 1999-11-15 Process and intermediates for preparing 5-lipoxygenase inhbitors.

Country Status (22)

Country Link
US (1) US6194585B1 (cs)
EP (1) EP1029865B1 (cs)
JP (2) JP3468729B2 (cs)
KR (1) KR100362789B1 (cs)
CN (1) CN1258675A (cs)
AR (1) AR019497A3 (cs)
AT (1) ATE265460T1 (cs)
AU (1) AU6539199A (cs)
BR (1) BR9905918A (cs)
CA (1) CA2289422A1 (cs)
CZ (1) CZ453699A3 (cs)
DE (1) DE69916778D1 (cs)
HU (1) HUP9904282A3 (cs)
ID (1) ID24014A (cs)
IL (1) IL132897A0 (cs)
IN (1) IN187165B (cs)
PL (1) PL337397A1 (cs)
RU (1) RU2181722C2 (cs)
TR (1) TR199903204A2 (cs)
TW (1) TW455586B (cs)
YU (1) YU59399A (cs)
ZA (1) ZA997113B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4569187B2 (ja) * 2004-06-17 2010-10-27 宇部興産株式会社 4−シアノテトラヒドロピランの製法
EP1834953A1 (en) * 2006-03-14 2007-09-19 Ranbaxy Laboratories Limited Tetrahydropyrane derivatives as 5-lipoxygenase inhibitors
AU2007327004A1 (en) * 2006-11-27 2008-06-05 Pfizer Products Inc. Pyrazole analogs
EP3563842A1 (en) 2009-04-29 2019-11-06 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0462830B1 (en) * 1990-06-21 1995-10-18 Zeneca Limited Cyclic ether derivatives
IE913866A1 (en) * 1990-11-28 1992-06-03 Ici Plc Aryl derivatives
EP0505122A1 (en) * 1991-03-21 1992-09-23 Zeneca Limited Alpha, alpha-dialkylbenzyl derivatives
EP0540165A1 (en) * 1991-10-03 1993-05-05 Zeneca Limited Alkanoic acid derivatives
US5753682A (en) * 1993-06-14 1998-05-19 Pfizer Inc. Imidazole lipoxygenase inhibitors
US5883106A (en) * 1994-10-18 1999-03-16 Pfizer Inc. 5-lipoxygenase inhibitors
SK281577B6 (sk) * 1994-10-18 2001-05-10 Pfizer Inc. Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze

Also Published As

Publication number Publication date
KR100362789B1 (ko) 2002-11-30
AR019497A3 (es) 2002-02-20
JP2004002415A (ja) 2004-01-08
ID24014A (id) 2000-06-22
HU9904282D0 (en) 2000-01-28
US6194585B1 (en) 2001-02-27
MX9912076A (cs) 2000-04-30
CZ453699A3 (cs) 2000-07-12
JP2000191654A (ja) 2000-07-11
CN1258675A (zh) 2000-07-05
TR199903204A2 (xx) 2000-07-21
BR9905918A (pt) 2000-09-26
TW455586B (en) 2001-09-21
EP1029865B1 (en) 2004-04-28
JP3468729B2 (ja) 2003-11-17
CA2289422A1 (en) 2000-06-22
KR20000052537A (ko) 2000-08-25
YU59399A (sh) 2002-11-15
EP1029865A3 (en) 2000-11-08
RU2181722C2 (ru) 2002-04-27
EP1029865A2 (en) 2000-08-23
IL132897A0 (en) 2001-03-19
HUP9904282A3 (en) 2001-04-28
DE69916778D1 (de) 2004-06-03
HUP9904282A2 (hu) 2000-12-28
PL337397A1 (en) 2000-07-03
IN187165B (cs) 2002-02-23
AU6539199A (en) 2000-06-29
ATE265460T1 (de) 2004-05-15

Similar Documents

Publication Publication Date Title
GB9816385D0 (en) Process
CZ20012118A3 (cs) Způsob výroby 3-alkanoylindolu a 3-alkylindolu
EG23373A (en) Process and intermediates.
GB9827884D0 (en) Process
HUP0101779A3 (en) Process for de-chlorinating and de-fouling waste-oil
IL145201A0 (en) Cooking machine and associated cooking method
ZA997113B (en) Process and intermediates for preparing 5-lipoxygenase inhbitors.
GB9806527D0 (en) Process
ZA982850B (en) Processes and intermediates for preparing 2-fluorothiophene derivatives.
ZA99277B (en) A process for preparing naphthyridones and intermediates.
HU9800619D0 (en) Fermentation process
HK1031881A1 (en) Process for preparing 8-cyclopentyl-6-ethyl-3-Äsu bstitutedÜ-5,8-dihydro-4H-1,2,3A, 7,8-pentaaza-as-indacenes and intermediates useful therein.
GB2335866B (en) Process
ZA992280B (en) Metallic knob and method for making it.
GB9828103D0 (en) Process
GB9820914D0 (en) Process
ZA996624B (en) Process and intermediates for preparing nicotinamide derivatives.
HU9801027D0 (en) Laser-inks, process for making and use thereof
AUPP276998A0 (en) Process and solution for extracting metal
ZA200109011B (en) New Process.
AUPP569798A0 (en) Brewing process
GB9820678D0 (en) Improved cooking method
GB9805521D0 (en) AN improved food process
GB9805195D0 (en) Process
GB9801313D0 (en) Process